COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture.

CMR COVID-19 OCT SARS-CoV-2 convalescence heart magnetic resonance myocardial infarction myocarditis recovery thrombosis

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
04 2021
Historique:
revised: 10 12 2020
received: 09 08 2020
accepted: 14 12 2020
pubmed: 8 1 2021
medline: 10 4 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Increased risk of cardiovascular complications during and post-COVID-19 infection is more and more recognized-including myocarditis, arrhythmias, and myocardial infarctions (MIs). The mechanisms leading to these complications are direct virus-induced injuries, as well as potential thrombotic and inflammatory-induced mechanisms. To the latter, inflammatory plaque instability and plaque rupture are discussed entities contributing to MI-induced post-COVID-19 complications. Our case report describes the first time, when a temporary impairment of LVEF in the COVID-19-convalescence phase unmasks a silent MI due to coronary plaque rupture by using invasive (OCT) and non-invasive (CMR) modalities. Myocardial infarction might be an important differential diagnosis to consider in deteriorating patients with COVID-19, especially if dyspnoea persists after acute infection.

Identifiants

pubmed: 33410259
doi: 10.1002/ehf2.13186
pmc: PMC8006695
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

971-973

Subventions

Organisme : BMBF (German Ministry of Education and Research)
Organisme : DZHK (German Centre for Cardiovascular Research)
Organisme : Philips Healthcare

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
ESC Heart Fail. 2021 Apr;8(2):971-973
pubmed: 33410259
Circulation. 2020 Jun 23;141(25):2113-2116
pubmed: 32352306
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Eur J Heart Fail. 2020 Jun;22(6):922-925
pubmed: 32430971
J Cardiovasc Magn Reson. 2020 Sep 3;22(1):61
pubmed: 32878639

Auteurs

Carsten Tschöpe (C)

Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Berlin Institute of Health (BIH) Berlin-Brandenburg Center for Regenerative Therapy (BCRT), Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.

Mohammad Sherif (M)

Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.

Markus S Anker (MS)

Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.
Division of Cardiology and Metabolism, Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin-Franklin, Berlin, Germany.
Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.

Dominik Geisel (D)

Department of Radiology, Campus Virchow Klinikum, Charité-University Medicine Berlin, Berlin, Germany.

Titus Kuehne (T)

Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.
Department of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.
Institute for Imaging Science and Computational Modelling in Cardiovascular Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Sebastian Kelle (S)

Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.
Department of Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH